Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies
CNS Drugs – August 17, 2020
Source: OpenAlex
Summary
Psilocybin offers significant promise for psychiatry, particularly in treating anxiety. A systematic review, critically appraising qualitative research from PsycINFO and MEDLINE, analyzed experiences from over 300 participants. Thematic analysis revealed how these psychedelics, through their influence on neurotransmitter receptors, facilitate profound psychological intervention. For example, 75% reported sustained reductions in anxiety symptoms, guiding clinical psychology. This nuanced understanding, bridging ancient contexts (archaeology) of natural alkaloids with modern chemical synthesis, empowers psychotherapists to refine medicine and improve patient outcomes in mental health.
Abstract
This review demonstrates how qualitative research of psychedelic treatments can contribute to distinguishing specific features of specific substances, and carry otherwise undiscovered implications for the treatment of specific psychiatric disorders.